- Published at
- by gurufocus.com
positive
positive
Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 62nd ERA Congress
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present seven abstracts at the upcoming European Renal Association (ERA) Congr